Boehringer Ingelheim Venture Fund

Boehringer backs T3 to take bacterial cancer therapy into clinic
Fierce Biotech
Wed, 07/22/20 - 10:43 am
T3 Pharmaceuticals
Boehringer Ingelheim Venture Fund
cancer
Boehringer Ingelheim fuels gene therapy startup focused on eye diseases
Fierce Biotech
Fri, 04/12/13 - 01:49 pm
Boehringer Ingelheim
gene therapy
Eyevensys
Boehringer Ingelheim Venture Fund